JP2017531430A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017531430A5 JP2017531430A5 JP2017518478A JP2017518478A JP2017531430A5 JP 2017531430 A5 JP2017531430 A5 JP 2017531430A5 JP 2017518478 A JP2017518478 A JP 2017518478A JP 2017518478 A JP2017518478 A JP 2017518478A JP 2017531430 A5 JP2017531430 A5 JP 2017531430A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- imp
- inhibitory
- dimerization
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 25
- 238000006471 dimerization reaction Methods 0.000 claims 23
- 210000002865 immune cell Anatomy 0.000 claims 20
- 230000002401 inhibitory effect Effects 0.000 claims 19
- 238000000034 method Methods 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 8
- 230000009977 dual effect Effects 0.000 claims 7
- 230000011664 signaling Effects 0.000 claims 6
- 102000018697 Membrane Proteins Human genes 0.000 claims 5
- 108010052285 Membrane Proteins Proteins 0.000 claims 5
- 230000003834 intracellular effect Effects 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 230000004913 activation Effects 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 108010089791 Eukaryotic Initiation Factor-2 Proteins 0.000 claims 2
- 102100027327 Eukaryotic translation initiation factor 2 subunit 2 Human genes 0.000 claims 2
- -1 SMAD10 Proteins 0.000 claims 2
- 108091008874 T cell receptors Proteins 0.000 claims 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 claims 1
- 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims 1
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 1
- 102100022970 Basic leucine zipper transcriptional factor ATF-like Human genes 0.000 claims 1
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 claims 1
- 102100024263 CD160 antigen Human genes 0.000 claims 1
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims 1
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 1
- 108090000397 Caspase 3 Proteins 0.000 claims 1
- 102100026549 Caspase-10 Human genes 0.000 claims 1
- 102100029855 Caspase-3 Human genes 0.000 claims 1
- 102100038918 Caspase-6 Human genes 0.000 claims 1
- 102100038902 Caspase-7 Human genes 0.000 claims 1
- 102100026548 Caspase-8 Human genes 0.000 claims 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 1
- 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 claims 1
- 101000809594 Escherichia coli (strain K12) Shikimate kinase 1 Proteins 0.000 claims 1
- 102100026693 FAS-associated death domain protein Human genes 0.000 claims 1
- 102100027581 Forkhead box protein P3 Human genes 0.000 claims 1
- 102100040754 Guanylate cyclase soluble subunit alpha-1 Human genes 0.000 claims 1
- 102100040735 Guanylate cyclase soluble subunit alpha-2 Human genes 0.000 claims 1
- 102100040739 Guanylate cyclase soluble subunit beta-1 Human genes 0.000 claims 1
- 102100028963 Guanylate cyclase soluble subunit beta-2 Human genes 0.000 claims 1
- 101150046249 Havcr2 gene Proteins 0.000 claims 1
- 102100028008 Heme oxygenase 2 Human genes 0.000 claims 1
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 1
- 102100035081 Homeobox protein TGIF1 Human genes 0.000 claims 1
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 claims 1
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 1
- 101000903742 Homo sapiens Basic leucine zipper transcriptional factor ATF-like Proteins 0.000 claims 1
- 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims 1
- 101000983518 Homo sapiens Caspase-10 Proteins 0.000 claims 1
- 101000741087 Homo sapiens Caspase-6 Proteins 0.000 claims 1
- 101000741014 Homo sapiens Caspase-7 Proteins 0.000 claims 1
- 101000983528 Homo sapiens Caspase-8 Proteins 0.000 claims 1
- 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 claims 1
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims 1
- 101001038755 Homo sapiens Guanylate cyclase soluble subunit alpha-1 Proteins 0.000 claims 1
- 101001038749 Homo sapiens Guanylate cyclase soluble subunit alpha-2 Proteins 0.000 claims 1
- 101001038731 Homo sapiens Guanylate cyclase soluble subunit beta-1 Proteins 0.000 claims 1
- 101001059095 Homo sapiens Guanylate cyclase soluble subunit beta-2 Proteins 0.000 claims 1
- 101001079615 Homo sapiens Heme oxygenase 2 Proteins 0.000 claims 1
- 101000596925 Homo sapiens Homeobox protein TGIF1 Proteins 0.000 claims 1
- 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 claims 1
- 101001003149 Homo sapiens Interleukin-10 receptor subunit beta Proteins 0.000 claims 1
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 claims 1
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 claims 1
- 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 1
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 1
- 101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 claims 1
- 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 claims 1
- 101001068027 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Proteins 0.000 claims 1
- 101001068019 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Proteins 0.000 claims 1
- 101000836954 Homo sapiens Sialic acid-binding Ig-like lectin 10 Proteins 0.000 claims 1
- 101000863882 Homo sapiens Sialic acid-binding Ig-like lectin 7 Proteins 0.000 claims 1
- 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 claims 1
- 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 claims 1
- 101000863692 Homo sapiens Ski oncogene Proteins 0.000 claims 1
- 101000688996 Homo sapiens Ski-like protein Proteins 0.000 claims 1
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 claims 1
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 1
- 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims 1
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims 1
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims 1
- 101001135589 Homo sapiens Tyrosine-protein phosphatase non-receptor type 22 Proteins 0.000 claims 1
- 101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 claims 1
- 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 claims 1
- 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 claims 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims 1
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 claims 1
- 102000017578 LAG3 Human genes 0.000 claims 1
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 claims 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 claims 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 claims 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 claims 1
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 claims 1
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 claims 1
- 102100024894 PR domain zinc finger protein 1 Human genes 0.000 claims 1
- 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 claims 1
- 108010009975 Positive Regulatory Domain I-Binding Factor 1 Proteins 0.000 claims 1
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 1
- 102100034464 Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Human genes 0.000 claims 1
- 102100034470 Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Human genes 0.000 claims 1
- 102100027164 Sialic acid-binding Ig-like lectin 10 Human genes 0.000 claims 1
- 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 claims 1
- 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 claims 1
- 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 claims 1
- 102100029969 Ski oncogene Human genes 0.000 claims 1
- 102100024451 Ski-like protein Human genes 0.000 claims 1
- 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 claims 1
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 1
- 102100035268 T-cell surface protein tactile Human genes 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 108091007178 TNFRSF10A Proteins 0.000 claims 1
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 claims 1
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 claims 1
- 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 claims 1
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims 1
- 102100033138 Tyrosine-protein phosphatase non-receptor type 22 Human genes 0.000 claims 1
- 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 claims 1
- 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000005931 immune cell recruitment Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 1
- 229960002930 sirolimus Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470623 | 2014-10-07 | ||
| DKPA201470623 | 2014-10-07 | ||
| PCT/EP2015/073197 WO2016055551A1 (en) | 2014-10-07 | 2015-10-07 | Method for modulating car-induced immune cells activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017531430A JP2017531430A (ja) | 2017-10-26 |
| JP2017531430A5 true JP2017531430A5 (enExample) | 2018-11-08 |
Family
ID=51730284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017518478A Pending JP2017531430A (ja) | 2014-10-07 | 2015-10-07 | Ｃａｒによって誘導される免疫細胞の活性を調節するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10472613B2 (enExample) |
| EP (1) | EP3204491A1 (enExample) |
| JP (1) | JP2017531430A (enExample) |
| KR (1) | KR20170068539A (enExample) |
| CN (1) | CN107109368A (enExample) |
| AU (1) | AU2015330017A1 (enExample) |
| BR (1) | BR112017007003A2 (enExample) |
| CA (1) | CA2963327A1 (enExample) |
| IL (1) | IL251429A0 (enExample) |
| MX (1) | MX2017004603A (enExample) |
| RU (1) | RU2017115808A (enExample) |
| WO (1) | WO2016055551A1 (enExample) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3300745T (pt) | 2013-02-15 | 2019-11-27 | Univ California | Recetor de antigénio quimérico e métodos de utilização do mesmo |
| US11253546B2 (en) | 2014-12-15 | 2022-02-22 | The Regents Of The University Of California | Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20 |
| JP6895380B2 (ja) * | 2015-02-06 | 2021-06-30 | ナショナル ユニバーシティ オブ シンガポール | 治療免疫細胞の有効性を改良するための方法 |
| US20170151281A1 (en) | 2015-02-19 | 2017-06-01 | Batu Biologics, Inc. | Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer |
| JP2018515123A (ja) | 2015-05-18 | 2018-06-14 | ティーシーアール２ セラピューティクス インク． | 融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法 |
| WO2016187594A1 (en) | 2015-05-21 | 2016-11-24 | Harpoon Therapeutics, Inc. | Trispecific binding proteins and methods of use |
| CN107849112B (zh) * | 2015-06-25 | 2022-04-01 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(car)、组合物及其使用方法 |
| EP3377523A4 (en) * | 2015-11-19 | 2019-06-19 | The Regents of The University of California | CONDITIONALLY REPRIMATABLE IMMUNOCELL RECEPTORS AND METHOD FOR USE THEREOF |
| CN109310727B (zh) * | 2016-01-08 | 2022-09-27 | 加利福尼亚大学董事会 | 有条件活性的异二聚体多肽及其使用方法 |
| WO2017192536A1 (en) | 2016-05-02 | 2017-11-09 | University Of Kansas | Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| JP7101621B2 (ja) | 2016-05-20 | 2022-07-15 | ハープーン セラピューティクス，インク． | 単一ドメイン血清アルブミン結合タンパク質 |
| GB201609604D0 (en) * | 2016-06-01 | 2016-07-13 | Ucl Business Plc | Cell |
| EP3494138A1 (en) | 2016-08-02 | 2019-06-12 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| DK3757120T3 (da) | 2016-10-04 | 2022-07-25 | Prec Biosciences Inc | Co-stimulerende domæner til anvendelse i genetisk modificerede celler |
| IL292551B2 (en) | 2016-10-07 | 2023-10-01 | Tcr2 Therapeutics Inc | Preparations and methods for reprogramming T-cell receptors using fusion proteins |
| AU2017363311A1 (en) | 2016-11-22 | 2019-06-13 | TCR2 Therapeutics Inc. | Compositions and methods for TCR reprogramming using fusion proteins |
| AU2017363278B2 (en) | 2016-11-22 | 2022-10-27 | National University Of Singapore | Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies |
| CA3044729A1 (en) | 2016-11-23 | 2018-05-31 | Harpoon Therapeutics, Inc. | Psma targeting trispecific proteins and methods of use |
| KR20210087108A (ko) | 2016-11-23 | 2021-07-09 | 하푼 테라퓨틱스, 인크. | 전립선 특이 막 항원 결합 단백질 |
| US11535668B2 (en) | 2017-02-28 | 2022-12-27 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| WO2018164948A1 (en) * | 2017-03-09 | 2018-09-13 | The Scripps Research Institute | Vectors with self-directed cpf1-dependent switches |
| IL300964A (en) | 2017-05-12 | 2023-04-01 | Harpoon Therapeutics Inc | mesothelin binding proteins |
| WO2018209304A1 (en) | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Msln targeting trispecific proteins and methods of use |
| CA3062727A1 (en) * | 2017-05-15 | 2018-11-22 | Autolus Limited | A cell comprising a chimeric antigen receptor (car) |
| JP2020524512A (ja) | 2017-06-21 | 2020-08-20 | アイセル・ジーン・セラピューティクス・エルエルシー | キメラ抗体受容体（ＣＡＲｓ）の組成物およびその使用方法 |
| CA3071282A1 (en) | 2017-08-10 | 2019-02-14 | National University Of Singapore | T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof |
| JP7654240B2 (ja) | 2017-09-19 | 2025-04-01 | マサチューセッツ インスティテュート オブ テクノロジー | キメラ抗原受容体ｔ細胞治療のための組成物およびその使用 |
| PE20201183A1 (es) | 2017-10-13 | 2020-11-03 | Harpoon Therapeutics Inc | Proteinas trispecificas y metodos de uso |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B-cell maturation antigen-binding proteins |
| JP2021500882A (ja) * | 2017-10-18 | 2021-01-14 | プレシゲン，インコーポレイテッド | スペーサーを含むポリペプチド組成物 |
| MX2020004444A (es) * | 2017-10-19 | 2020-07-22 | Cellectis | Integracion genica direccionada de genes de inhibidores de nk para terapia con celulas inmunes mejorada. |
| GB201717524D0 (en) | 2017-10-25 | 2017-12-06 | Autolus Ltd | Vectors |
| SG11202005307RA (en) * | 2017-12-14 | 2020-07-29 | Bluebird Bio Inc | Nkg2d daric receptors |
| JP7394058B2 (ja) * | 2017-12-21 | 2023-12-07 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 新規抗原結合部分の特異性試験のためのユニバーサルレポーター細胞アッセイ |
| CN111867619A (zh) | 2018-01-03 | 2020-10-30 | 曲生物制品公司 | 过继性细胞治疗的先天寻靶 |
| AR114273A1 (es) * | 2018-03-02 | 2020-08-12 | Allogene Therapeutics Inc | Receptores inducibles de citoquina quimérica |
| US10780120B2 (en) | 2018-03-06 | 2020-09-22 | The Trustees Of The University Of Pennsylvania | Prostate-specific membrane antigen cars and methods of use thereof |
| CA3096500A1 (en) | 2018-04-13 | 2019-10-17 | Sangamo Therapeutics France | Chimeric antigen receptor specific for interleukin-23 receptor |
| EP3774866A1 (en) | 2018-04-13 | 2021-02-17 | Ludwig Institute for Cancer Research Ltd | Heterodimeric inactivatable chimeric antigen receptors |
| KR20210020903A (ko) | 2018-05-14 | 2021-02-24 | 하푼 테라퓨틱스, 인크. | 면역글로불린 분자의 조건부 활성화를 위한 결합 모이어티 |
| SG11202010996QA (en) | 2018-05-23 | 2020-12-30 | Nat Univ Singapore | Blockade of cd2 surface expression and expression of chimeric antigen receptors for immunotherapy of t-cell malignancies |
| CN112292147A (zh) * | 2018-06-19 | 2021-01-29 | 南京传奇生物科技有限公司 | 工程化的细胞及其用途 |
| WO2020061482A1 (en) | 2018-09-21 | 2020-03-26 | Harpoon Therapeutics, Inc. | Egfr binding proteins and methods of use |
| CA3114038A1 (en) | 2018-09-25 | 2020-04-02 | Harpoon Therapeutics, Inc. | Dll3 binding proteins and methods of use |
| CA3113618A1 (en) | 2018-09-28 | 2020-04-02 | Massachusetts Institute Of Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| EP3876977A1 (en) | 2018-11-06 | 2021-09-15 | The Regents Of The University Of California | Chimeric antigen receptors for phagocytosis |
| CN113347991B (zh) | 2019-01-23 | 2024-07-30 | 美天施生物科技有限两合公司 | 用于消除和增强受试者骨髓中造血干细胞植入的组合物的组合 |
| EP3931208A1 (en) | 2019-03-01 | 2022-01-05 | Allogene Therapeutics, Inc. | Chimeric cytokine receptors bearing a pd-1 ectodomain |
| PH12021551861A1 (en) | 2019-03-01 | 2022-05-30 | Allogene Therapeutics Inc | Constitutively active chimeric cytokine receptors |
| US11026973B2 (en) | 2019-04-30 | 2021-06-08 | Myeloid Therapeutics, Inc. | Engineered phagocytic receptor compositions and methods of use thereof |
| CN110079504A (zh) * | 2019-05-06 | 2019-08-02 | 山东大学第二医院 | 一种含有不稳定结构域的car-t细胞及其制备方法和调节car-t细胞功能方法 |
| CN114245806A (zh) | 2019-05-14 | 2022-03-25 | 哈普恩治疗公司 | EpCAM结合蛋白及使用方法 |
| WO2020247837A1 (en) * | 2019-06-07 | 2020-12-10 | The Trustees Of The University Of Pennsylvania | Dual car expressing t cells individually linked to cd28 and 4-1bb |
| EP3990491A1 (en) | 2019-06-26 | 2022-05-04 | Massachusetts Institute of Technology | Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof |
| BR112022003553A2 (pt) | 2019-08-30 | 2022-05-24 | Allogene Therapeutics Inc | Receptores de citocina quiméricos compreendendo domínios de ligação a tgf beta |
| MX2022002613A (es) | 2019-09-03 | 2022-06-02 | Myeloid Therapeutics Inc | Metodos y composiciones para la integracion del genoma. |
| WO2021061648A1 (en) | 2019-09-23 | 2021-04-01 | Massachusetts Institute Of Technology | Methods and compositions for stimulation of endogenous t cell responses |
| AU2020378263A1 (en) | 2019-11-05 | 2022-06-23 | Janssen Biotech, Inc. | BCMA-targeted CAR-T cell therapy of multiple myeloma |
| US10980836B1 (en) | 2019-12-11 | 2021-04-20 | Myeloid Therapeutics, Inc. | Therapeutic cell compositions and methods of manufacturing and use thereof |
| EP4100027A1 (en) | 2020-02-04 | 2022-12-14 | Miltenyi Biotec B.V. & Co. KG | Immune cell expressing adapter chimeric antigen receptor for sensing soluble antigens |
| AU2021224851A1 (en) | 2020-02-21 | 2022-09-15 | Harpoon Therapeutics, Inc. | FLT3 binding proteins and methods of use |
| CN115175929A (zh) | 2020-02-24 | 2022-10-11 | 艾洛基治疗公司 | 活性增强的bcma car-t细胞 |
| WO2021221782A1 (en) | 2020-05-01 | 2021-11-04 | Massachusetts Institute Of Technology | Chimeric antigen receptor-targeting ligands and uses thereof |
| WO2021221783A1 (en) | 2020-05-01 | 2021-11-04 | Massachusetts Institute Of Technology | Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof |
| US12286465B2 (en) | 2020-05-28 | 2025-04-29 | Miltenyi Biotec B.V. & Co. KG | Chimeric antigen receptor with a spacer comprising C2-set Ig-like domains |
| CN112080527A (zh) * | 2020-09-16 | 2020-12-15 | 南京市第一医院 | 重组表达载体、耗竭减少的嵌合抗原受体t细胞及其应用 |
| JP2023549140A (ja) | 2020-11-04 | 2023-11-22 | マイエロイド・セラピューティクス，インコーポレーテッド | 操作されたキメラ融合タンパク質組成物およびその使用方法 |
| US20230405047A1 (en) | 2020-11-09 | 2023-12-21 | Miltenyi Biotec B.V. & Co. KG | Methods and compositions for eliminating engineered immune cells |
| JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス，インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
| EP4284822A1 (en) * | 2021-01-29 | 2023-12-06 | Outpace Bio, Inc. | Small molecule-regulated cell signaling expression system |
| AU2022237618A1 (en) | 2021-03-17 | 2023-10-12 | Create Medicines, Inc. | Engineered chimeric fusion protein compositions and methods of use thereof |
| WO2022241029A1 (en) | 2021-05-11 | 2022-11-17 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| WO2023057285A1 (en) | 2021-10-06 | 2023-04-13 | Miltenyi Biotec B.V. & Co. KG | Method for targeted gene insertion into immune cells |
| WO2023081715A1 (en) | 2021-11-03 | 2023-05-11 | Viracta Therapeutics, Inc. | Combination of car t-cell therapy with btk inhibitors and methods of use thereof |
| WO2024078995A1 (en) | 2022-10-15 | 2024-04-18 | Miltenyi Biotec B.V. & Co. KG | Transduction of gammadelta t cells with pseudotyped retroviral vectors |
| WO2024086191A2 (en) * | 2022-10-18 | 2024-04-25 | Kite Pharma, Inc. | Car-t constructs comprising a novel cd19 binder combined with il18 and methods of using the same |
| CN116023507A (zh) * | 2022-10-25 | 2023-04-28 | 中国医学科学院基础医学研究所 | 嵌合抗原受体巨噬细胞在实体肿瘤免疫治疗中的应用 |
| WO2024227145A1 (en) * | 2023-04-27 | 2024-10-31 | Memorial Sloan-Kettering Cancer Center | Enhanced fusion polypeptide for immunotherapy |
| KR102764613B1 (ko) * | 2024-03-28 | 2025-02-12 | 한양대학교 에리카산학협력단 | NaPi2b 특이적 CAR-T를 포함하는 난소암 치료용 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| PT3300745T (pt) * | 2013-02-15 | 2019-11-27 | Univ California | Recetor de antigénio quimérico e métodos de utilização do mesmo |
| EP2964753B1 (en) | 2013-03-07 | 2018-04-25 | Baylor College of Medicine | Targeting cd138 in cancer |
| CA2907397C (en) * | 2013-03-15 | 2022-11-22 | Anthrogenesis Corporation | Modified t lymphocytes |
| WO2014145252A2 (en) * | 2013-03-15 | 2014-09-18 | Milone Michael C | Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy |
| TWI654206B (zh) * | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
-
2015
- 2015-10-07 EP EP15778276.4A patent/EP3204491A1/en not_active Withdrawn
- 2015-10-07 MX MX2017004603A patent/MX2017004603A/es unknown
- 2015-10-07 CA CA2963327A patent/CA2963327A1/en not_active Abandoned
- 2015-10-07 CN CN201580066604.9A patent/CN107109368A/zh active Pending
- 2015-10-07 WO PCT/EP2015/073197 patent/WO2016055551A1/en not_active Ceased
- 2015-10-07 US US15/517,708 patent/US10472613B2/en active Active
- 2015-10-07 RU RU2017115808A patent/RU2017115808A/ru not_active Application Discontinuation
- 2015-10-07 KR KR1020177012493A patent/KR20170068539A/ko not_active Withdrawn
- 2015-10-07 AU AU2015330017A patent/AU2015330017A1/en not_active Abandoned
- 2015-10-07 JP JP2017518478A patent/JP2017531430A/ja active Pending
- 2015-10-07 BR BR112017007003A patent/BR112017007003A2/pt not_active IP Right Cessation
-
2017
- 2017-03-28 IL IL251429A patent/IL251429A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017531430A5 (enExample) | ||
| RU2017115808A (ru) | Способ модуляции активности car-индуцированных иммунных клеток | |
| Gargett et al. | GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 blockade | |
| Cheng et al. | In vivo expansion and antitumor activity of coinfused CD28-and 4-1BB-engineered CAR-T cells in patients with B cell leukemia | |
| TWI790213B (zh) | 用於使用融合蛋白之tcr重編程的組合物及方法 | |
| JP6905163B2 (ja) | サイトカイン放出症候群を予測するバイオマーカー | |
| JP7604366B2 (ja) | 遺伝子操作されたｔ細胞を作製するための方法 | |
| JP7388798B2 (ja) | Ｓｕｖ３９ｈ１を欠損する免疫細胞 | |
| Wu et al. | B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity | |
| US20210189336A1 (en) | Bite-activated car-t cells | |
| JP2018529327A5 (enExample) | ||
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| CA3108951A1 (en) | Single-chain chimeric polypeptides and uses thereof | |
| JP2017513478A5 (enExample) | ||
| CN111032850A (zh) | 寡聚粒子试剂及其使用方法 | |
| Alonso-Camino et al. | CARbodies: human antibodies against cell surface tumor antigens selected from repertoires displayed on T cell chimeric antigen receptors | |
| JP2019514393A (ja) | 細胞に基づくネオ抗原ワクチンおよびその使用 | |
| WO2017064084A1 (en) | Novel chimeric antigen receptors | |
| KR20230007559A (ko) | 태그된 키메라 이펙터 분자 및 그의 리셉터 | |
| JP2018528786A5 (enExample) | ||
| Birley et al. | A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers | |
| Chen et al. | Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma | |
| JP2026500718A (ja) | Ｂ７－ｈ３を標的とする抗体または抗体断片、およびキメラ抗原受容体免疫細胞療法の分野におけるその使用 | |
| Biederstädt et al. | Engineered natural killer cells for cancer therapy | |
| KR20240145092A (ko) | 입양 세포 요법을 위해 표적화된 공동자극을 제공하는 수용체 |